National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Thyroid Cancer Treatment (PDQ®)
Patient VersionHealth Professional VersionEn españolLast Modified: 09/23/2009



Purpose of This PDQ Summary






General Information







Cellular Classification






Stage Information






Stage I and II Papillary and Follicular Thyroid Cancer






Stage III Papillary and Follicular Thyroid Cancer






Stage IV Papillary and Follicular Thyroid Cancer






Medullary Thyroid Cancer






Anaplastic Thyroid Cancer






Recurrent Thyroid Cancer






Get More Information From NCI






Changes to This Summary (09/23/2009)






More Information



Page Options
Print This Page  Print This Page
Print This Document  Print Entire Document
View Entire Document  View Entire Document
E-Mail This Document  E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Office of Biorepositories and Biospecimen Research

The Nation's Investment in Cancer Research FY 2010

Report to Nation Finds Declines in Cancer Incidence, Death Rates
Cellular Classification

Cell type is an important determinant of prognosis in thyroid cancer. There are four main varieties of thyroid cancer (although, for clinical management of the patient, thyroid cancer is generally divided into two categories: well differentiated or poorly differentiated):[1]

  • Papillary carcinoma.
    • Papillary/follicular carcinoma.
  • Follicular carcinoma.
    • Hürthle cell carcinoma, a variant of follicular carcinoma with a poorer prognosis.[2,3]
  • Medullary carcinoma.
  • Anaplastic carcinoma.
    • Small cell carcinoma.
    • Giant cell carcinoma.
  • Others.
    • Lymphoma.
    • Sarcoma.
    • Carcinosarcoma.

A definition for each major type can be found under stage information.

References

  1. LiVolsi VA: Pathology of thyroid disease. In: Falk SA: Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. Philadelphia, Pa: Lippincott-Raven, 1997, pp 127-175. 

  2. Kushchayeva Y, Duh QY, Kebebew E, et al.: Comparison of clinical characteristics at diagnosis and during follow-up in 118 patients with Hurthle cell or follicular thyroid cancer. Am J Surg 195 (4): 457-62, 2008.  [PUBMED Abstract]

  3. Mills SC, Haq M, Smellie WJ, et al.: Hürthle cell carcinoma of the thyroid: Retrospective review of 62 patients treated at the Royal Marsden Hospital between 1946 and 2003. Eur J Surg Oncol 35 (3): 230-4, 2009.  [PUBMED Abstract]

Back to TopBack to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov